1. Moledina DG, Parikh CR. Phenotyping of acute kidney injury: beyond serum creatinine. Semin Nephrol. 2018; 38:3–11. PMID:
29291759.
2. Kim H, Hur M, Lee S, Marino R, Magrini L, Cardelli P, et al. Proenkephalin, neutrophil gelatinase-associated lipocalin, and estimated glomerular filtration rates in patients with sepsis. Ann Lab Med. 2017; 37:388–397. PMID:
28643487.
3. Klein SJ, Brandtner AK, Lehner GF, Ulmer H, Bagshaw SM, Wiedermann CJ, et al. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2018; 44:323–336. PMID:
29541790.
4. Hjortrup PB, Haase N, Wetterslev M, Perner A. Clinical review: predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients. Crit Care. 2013; 17:211. PMID:
23680259.
5. Kashani K, Cheungpasitporn W, Ronco C. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med. 2017; 55:1074–1089. PMID:
28076311.
6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Working Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009; (Suppl):S1–S130. PMID:
26746390.
7. Coca SG, Garg AX, Swaminathan M, Garwood S, Hong K, Thiessen-Philbrook H, et al. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant. 2013; 28:2787–2799. PMID:
24081864.
8. Cho SY, Hahn WH, Lee HJ, Suh JT, Lee A, Cho BS, et al. The clinical significance of serum cystatin C in critically ill newborns with normal serum creatinine. J Clin Lab Anal. 2012; 26:267–271. PMID:
22811360.
9. Yun BA, Yang EY, Kim CJ. Plasma neutrophil gelatinase-associated lipocalin as a predictor of renal parenchymal involvement in infants with febrile urinary tract infection: a preliminary study. Ann Lab Med. 2018; 38:425–430. PMID:
29797812.
10. Fiseha T, Tamir Z. Urinary markers of tubular injury in early diabetic nephropathy. Int J Nephrol. 2016; 2016:4647685. PMID:
27293888.
11. Malhotra R, Siew ED. Biomarkers for the early detection and prognosis of acute kidney injury. Clin J Am Soc Nephrol. 2017; 12:149–173. PMID:
27827308.
12. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004; 432:917–921. PMID:
15531878.
13. Tong J, Li H, Zhang H, Luo Z, Huang Y, Huang J, et al. Neutrophil gelatinase-associated lipocalin in the prediction of contrast-induced nephropathy: a systemic review and meta-analysis. J Cardiovasc Pharmacol. 2015; 66:239–245. PMID:
25915514.
14. Ronco C, Legrand M, Goldstein SL, Hur M, Tran N, Howell EC, et al. Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective. Blood Purif. 2014; 37:271–285. PMID:
25012891.